COMMUNIQUÉS West-GlobeNewswire

Tower One to Spin Out USA-Based TCTS

22/02/2018 - 15:00

VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (the “Company ” or “ Tower One ”) is pleased to announce that it intends to spin-out its [...]

Tetra Bio-Pharma Announces Filing of Restated Financial Statements and MD&A

22/02/2018 - 14:59

OTTAWA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Corporation ”) (TSX-V: TBP ) (OTCQB:TBPMF), announced today it has filed restated Condensed Consolidated interim financial statements ( [...]

Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

22/02/2018 - 14:45

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy

22/02/2018 - 14:44

CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]

Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter

22/02/2018 - 14:39

NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), announced today that within the first half of Q1-2018 it has set up trials for pathology lab services with 4 times as many new oncology [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

22/02/2018 - 14:01

FIT Biotech Oy Company release February 22, 2018 at 3:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Vericel to Report Fourth-Quarter and Full-Year 2017 Financial Results on March 5, 2018

22/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast [...]

The Joint Corp. to Host Conference Call on Thursday, March 8, to Discuss Fourth Quarter and Full Year 2017 Results

22/02/2018 - 14:00

SCOTTSDALE, Ariz., Feb. 22, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, announced it will report its fourth quarter and full year 2017 [...]

ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population

22/02/2018 - 14:00

EDISON, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast

22/02/2018 - 14:00

NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

BioSig Technologies to Partner with Focus Marketing

22/02/2018 - 14:00

Santa Monica, CA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Chimerix to Announce Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018

22/02/2018 - 14:00

DURHAM, N.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that it [...]

Aegis Awarded Patent for Fast Acting Nasal Spray Opioid Blockers and Pain Medications

22/02/2018 - 14:00

SAN DIEGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 9,895,444 providing non-invasive metered nasal spray delivery of multiple opioid blockers such [...]

Hemostemix Signs Manufacturing Agreement with Aspire Health Science

22/02/2018 - 14:00

CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased to announce it has finalized the terms of a contract manufacturing services agreement [...]

Emerald Health Therapeutics Named as #1 2018 TSX Venture 50™ Performer

22/02/2018 - 14:00

VICTORIA, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V: EMH ) (OTCQX:EMHTF) ("Emerald") has achieved the #1 ranking in the 2018 TSX Venture 50™ for the clean technology [...]

Scythian Biosciences Corp. Announces Ringing of the Nasdaq Stock Market Closing Bell

22/02/2018 - 14:00

TORONTO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTCQB:SCCYF) is pleased to announce that the Company will ring the closing bell at [...]

Amedisys-Availity Relationship Yields Faster Payor Authorizations

22/02/2018 - 13:30

BATON ROUGE, La., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Thanks to a new relationship with Availity, LLC (“Availity”), Amedisys, Inc. (NASDAQ: AMED ), one of the nation’s leading home health, hospice and personal care [...]

Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period

22/02/2018 - 13:30

- Subscription period expected to end on March 2, 2018 at 5:00 PM ET NEW YORK, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") , announced today that [...]

XORTX Therapeutics Appoints Dave Matthews CFO

22/02/2018 - 13:30

CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney [...]